Stock summary: CARGO Therapeutics reflected weekly fall of 73.11%

CARGO Therapeutics Inc closed the week at 3.60 USD, experiencing a sharp decline of 9.79 points (-73.11%) over the past five days.

Advertisement

CARGO Therapeutics Inc closed the week at 3.60 USD, experiencing a sharp decline of 9.79 points (-73.11%) over the past five days. As of January 31 at 7:54 PM GMT-5, the stock showed a drop, indicating substantial market concerns. After hours, the stock further declined to 3.55 USD, losing 0.050 points (-1.39%).

During the session, CARGO Therapeutics reached a high of 3.72 USD, indicating some intraday positive movement, but it faced downward pressure as the stock closed much lower. The low of 3.38 USD highlights the volatility and sell-off during the day, marking a significant pullback from the highs. The opening price of the stock was at a total of 3.45 USD.

Currently, CARGO Therapeutics holds a market capitalization of 16.57 Cr USD. Despite the fact that on Friday’s closing the stock was rising, yet it showcased an overall declining performance throughout the week. This decline came after the health technology company announced discontinuation of  a phase 2 study of firicabtagene autoleucel, or firi-cel, for patients with large B-cell lymphoma and will also downsize its workforce by 50%.  

Advertisement

Disclaimer: This article is for informational purposes only and does not constitute any financial advice.